United States · FDA National Drug Code directory
CELECOXIB
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69097-422_8df39b9c-af70-4ac3-ba9f-6e8e795ba961
- Product NDC
- 69097-422
- Form
- CAPSULE
- Composition / generic term
- CELECOXIB
- Labeler
- Cipla USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20150923
- Source listing expiry
- 20261231
Source-listed ingredients
- CELECOXIB — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE in 1 BOTTLE (69097-422-02) · 69097-422-02
- 100 CAPSULE in 1 BOTTLE (69097-422-07) · 69097-422-07
- 500 CAPSULE in 1 BOTTLE (69097-422-12) · 69097-422-12
- 10 BLISTER PACK in 1 CARTON (69097-422-21) / 10 CAPSULE in 1 BLISTER PACK (69097-422-19) · 69097-422-21
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →